ENGINEERING MEDICINES TO IMPROVE PATIENT CARE Investors SEC Filing Details Document Details Form 10-Q Filing Date November 14, 2022 Document Date September 30, 2022 Form Description Quarterly report which provides a continuing view of a company's financial position Filing Group Quarterly Filings Company Viridian Therapeutics Inc. Issuer VIRIDIAN THERAPEUTICS, INC.\DE Filing Formats iXBRL View HTML Download PDF Download DOC Download XLS XBRL XBRL Viewer EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML - XBRL INSTANCE DOCUMENT
Document Details Form 10-Q Filing Date November 14, 2022 Document Date September 30, 2022 Form Description Quarterly report which provides a continuing view of a company's financial position Filing Group Quarterly Filings Company Viridian Therapeutics Inc. Issuer VIRIDIAN THERAPEUTICS, INC.\DE Filing Formats iXBRL View HTML Download PDF Download DOC Download XLS XBRL XBRL Viewer EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML - XBRL INSTANCE DOCUMENT